ArticleMedicine2026
Outcomes of sequential keratoplasty for bilateral gelatinous drop-like corneal dystrophy: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleGelatinous drop-like corneal dystrophy (GDLD) is a rare autosomal recessive disorder characterized by subepithelial amyloid deposition, progressive corneal opacification, and recurrent erosions. GDLD may present during the first decade of life and interfere with visual development. It may recur after keratoplasty, complicating surgical management. PATIENT CONCERNS: A 21-year-old woman of Yemeni ancestry, living in a remote area with limited access to corneal transplantation, presented with progressive left eye visual decline and foreign body sensation since early childhood. She had long-standing bilateral visual impairment and a positive family history. Her first surgery was right eye penetrating keratoplasty (PK), performed elsewhere approximately 1 year earlier for an undiagnosed opacity. DIAGNOSES: Examination revealed nystagmus, a clear right graft with yellowish recipient deposits, and dense limbus-to-limbus left corneal opacification with stromal haze, mulberry-like deposits, and neovascularization. Uncorrected visual acuity (VA) was 20/200 in the right eye and counting fingers in the left. Best spectacle-corrected VA was 20/100 in the right eye, while reliable refraction could not be obtained in the left. Histopathology demonstrated Congo red-positive subepithelial amyloid deposits with birefringence under polarized light, confirming GDLD. Genetic testing for tumor-associated calcium signal transducer 2 was not performed.
interventionsThe left eye underwent superficial keratectomy and attempted lamellar dissection assisted by intraoperative optical coherence tomography; dense deep stromal opacity necessitated conversion to full-thickness PK. OUTCOMES: Both grafts remained clear without rejection during follow-up. Minimal focal subepithelial haze in a temporal area of the left donor graft was noted at the 2 most recent visits, remained stationary between them, and was clinically insignificant. At final follow-up, approximately 2 years after right eye PK and 10 months after left eye PK, best spectacle-corrected VA was 20/100 in the right eye and 20/80 - 1 in the left. Intraocular pressure was normal, and posterior pole examinations were unremarkable. LESSONS: Advanced bilateral GDLD poses clinical and surgical challenges. PK may restore corneal clarity and provide meaningful visual rehabilitation, although recovery may remain incomplete after early-onset visual impairment and delayed treatment. Long-term monitoring is essential because recurrence and repeat intervention may be required. Early recognition, timely referral, and individualized management matter where donor corneal tissue access is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.